Caley Smith

Caley Smith, Ph.D., is a skilled research scientist and study director with expertise in gene therapy and pharmacology. Academic qualifications include a Doctor of Philosophy in Gene/Genetic Therapy from the University of Missouri-Columbia and a Bachelor of Science in Biology from Truman State University. Professional experience encompasses roles as a Doctoral Student at the University of Missouri-Columbia, focusing on spinal muscular atrophy and gene therapy efficacy; as a Research Scientist I at M6P Therapeutics, managing in vivo studies for lysosomal storage disorders; and presently as Study Director I at Inotiv, overseeing study protocols and ensuring compliance with regulatory standards. An early research position at A.T. Still University involved investigating the effects of microRNAs on melanoma metastasis.